Citations Database | Biointron

Product/Service

Antibody or Protein Production Catalog Products Antibody Discovery Hybridoma Sequencing

Journal

Acta Pharmaceutica Sinica B Advanced Healthcare Materials Antibodies Antibody Therapeutics Biosensors Cancer Immunology Research Cancer Letters Cancer Research Communications Cancers Carbohydrate Polymers Cell Biomaterials Cell Death and Disease Cell Research Cell Systems EMBO Molecular Medicine eBioMedicine European Journal of Immunology Food and Agricultural Immunology Frontiers in Immunology iScience Immunopharmacology and Immunotoxicology Immunotherapy JCI Insight Journal for ImmunoTherapy of Cancer Journal of Autoimmunity Journal of Bone and Mineral Research Journal of Healthcare Engineering Journal of Immunological Methods Journal of Immunotherapy Journal of Virology MAbs Molecular Cancer Therapeutics Molecular Metabolism Nature Chemical Biology Nature Communications Neurotoxicity Research npj Vaccines Oncogene Research Science Advances Science China Life Sciences Science Immunology Scientific Reports Small Viruses

FlowDesign: Improved Design of Antibody CDRs Through Flow Matching and Better Prior Distributions

Authors: Jun Wu, Xiangzhe Kong, Ningguan Sun, Jing Wei, Sisi Shan, Fuli Feng, Feng Wu, Jian Peng, Linqi Zhang, Yang Liu, Jianzhu Ma

Journal: Cell Systems

PubMed ID: 40306278

DOI: https://doi.org/10.1016/j.cels.2025.101270

Products & Services: Antibodies targeting CD4 d1-d2 were expressed by cloning into pcDNA3.4 (Biointron)

Apr 29, 2025

AZIN1-dependent polyamine synthesis accelerates tumor cell cycle progression and impairs effector T-cell function in osteosarcoma

Authors: Jiaming Yu, Chuanxia Zhang, Qinkai Zhang, Bing Lu, Guohao Lu, Chunxiao Zhang, Ru Qiu, Xinyue Wang, Changye Zou, Junjun Chu, Haizhou Li & Wei Zhao

Journal: Cell Death & Disease

PubMed ID: 40246846

DOI: https://doi.org/10.1038/s41419-025-07640-x

Products & Services: For PD-L1 blocking experiments, tumor cells were pre-treated with 10 µg/mL anti-PD-L1 antibody (Atezolizumab, #B2016, BIOINTRON)

Apr 17, 2025

Bifunctional chemokine-nanobody fusion protein enhances neutrophil recruitment to impede Acanthamoeba immune evasion

Authors: Zhenyu Wei, Jianlong Yuan, Qiankun Chen, Jinding Pang, Qingquan Shi, Bo Peng, Mingda Wei, Yuan Wei, Zhibao Zhang, Xinxin Lu, Xin Lin, Qingfeng Liang

Journal: eBioMedicine

PubMed ID: 40222104

DOI: https://doi.org/10.1016/j.jim.2025.113855

Products & Services: Monovalent VHH nanobody sequences and sequence of nanobody carrying mCXCL1 were synthesized by Biointron

Apr 12, 2025

Identification of polyreactive antibodies by high throughput enzyme-linked immunosorbent assay and surface Plasmon resonance

Authors: Luis Antonio Rodriguez Carnero, Daniel Bedinger, Simon Cocklin, Jianquan Li, M. Frank Erasmus, Sara D'Angelo, Camila Leal-Lopes, Andre Azevedo Reis Teixeira, Fortunato Ferrara, Andrew Raymon Morton Bradbury

Journal: Journal of Immunological Methods

PubMed ID: 40157637

DOI: https://doi.org/10.1016/j.jim2025.113855

Products & Services: Antibodies (except infliximab) were expressed in vitro in CHO cells and purified by protein G affinity chromatography (Biointron)

Apr 02, 2025

A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression

Authors: Victor S. Goldmacher, Iosif Gershteyn, Ravi Chari & Yelena Kovtun

Journal: Scientific Reports

PubMed ID: 40121208

DOI: https://doi.org/10.1038/s41598-025-93927-0

Products & Services: Monospecific and bispecific antibodies for this study were generated at BioIntron using standard transient expression procedures in CHO cells, followed by isolation through protein A chromatography.

Mar 22, 2025

Targeting FAK improves the tumor uptake of antibody-drug conjugates to strengthen the anti-cancer responses

Authors: Baoyuan Zhang, Zhixiang Zhang, Jiaming Gao, Shiqiang Lu, Ran Pang, Dongfang Li, Xun Huang, Natasha Qin, Leo Liu, Zaiqi Wang

Journal: iScience

PubMed ID: 40040813

DOI: https://doi.org/10.1016/j.isci.2024.111536

Products & Services: Sacituzumab was obtained from Biointron

Mar 21, 2025

Efficient Identification of Monoclonal Antibodies Against Rift Valley Fever Virus Using High-Throughput Single Lymphocyte Transcriptomics of Immunized Mice

Authors: Ronit Rosenfeld, Ron Alcalay, Yfat Yahalom-Ronen, Sharon Melamed, Avital Sarusi-Portuguez, Tal Noy-Porat, Ofir Israeli, Adi Beth-Din, Ronnie Blecher-Gonen, Theodor Chitlaru, Erez Bar-Haim, Tomer Israely, Anat Zvi and Efi Makdasi

Journal: Antibodies

PubMed ID: 39982227

DOI: https://doi.org/10.3390/antib14010012

Products & Services: Recombinant mAbs were produced on a small scale by Biointron Biotech Co., Ltd. (Shanghai, China; “RushMab” expression package)

Feb 04, 2025

Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells

Authors: Yeye Guo, Huaishan Wang, Shujing Liu, Xiaogang Zhang, Xingyue Zhu, Lili Huang, Wenqun Zhong, Lei Guan, Yeqing Chen, Min Xiao, Lingling Ou, Jingbo Yang, Xiang Chen, Alexander C. Huang, Tara Mitchell, Ravi Amaravadi, Giorgos Karakousis, John Miura, Lynn Schuchter, Ahron Flowers, Qiuxian Zheng, Haiwei Mou, Phyllis Gimotty, Meenhard Herlyn, Wei Guo, and Xiaowei Xu

Journal: Science Advances

PubMed ID: 39813334

DOI: https://doi.org/10.1126/sciadv.adp9009

Products & Services: DR5 monoclonal antibodies (tigatuzumab) were manufactured by Biointron

Jan 15, 2025

PlexinD1 is a driver and a therapeutic target in advanced prostate cancer

Authors: Jing Wei, Jing Wang, Wen Guan, Jingjing Li, Tianjie Pu, Eva Corey, Tzu-Ping Lin, Allen C Gao, and Boyang Jason Wu

Journal: EMBO Mol Med

PubMed ID: 39748059

DOI: https://doi.org/10.1038/s44321-024-00186-z

Products & Services: The D1SP sequence was generated by fusing a signal peptide sequence, human PlexinD1 Sema domain (aa 49–547) and PSI domain (aa 548–601), a G4S linker, and a hinge sequence to human IgG1 followed by codon optimization and synthesized by Biointron Biological

Jan 02, 2025

Epitope profiling of cow's milk allergen-specific antibodies with determining IgE content in epitopes-ALL, a 14-epitopes mixture

Authors: Yoshihiro Watanabe, Ikuo Okafuji, Satoko Tamai, Natsuko Hosokawa, Takako Ohbayashi, Shigeki Kato, Kiyoaki Ito, Mitsuhiro Kawano, Yusei Ohshima

Journal: Journal of Immunological Methods

PubMed ID: 39489375

DOI: https://doi.org/10.1016/j.jim.2024.113773

Products & Services: Chimeric sequences, produced in CHO and HEK293 cells, and purified at BioIntron Ltd. (Shanghai, China).

Dec 02, 2024